Repurposing the antibacterial agents peptide 19-4LF and peptide 19-2.5 for treatment of cutaneous leishmaniasis

Repurposing the antibacterial agents peptide 19-4LF and peptide 19-2.5 for treatment of cutaneous leishmaniasis

The lack of safe and cost-effective treatments against leishmaniasis highlights the urgent need to develop improved leishmanicidal agents. Antimicrobial peptides (AMPs) are an emerging category of therapeutics exerting a wide range of biological activities such as anti-bacterial, anti-fungal, anti-p...

Full description

Bibliographic Details
Main Authors: El-Dirany, R. (Rima), Fernández-Rubio, C. (Celia), Peña-Guerrero, J. (José), Moreno-Amatria, E. (Esther), Larrea, E. (Esther), Espuelas, S. (Socorro), Abdel-Sater, F. (Fadi), Brandenburg, K. (Klaus), Martinez-de-Tejada, G. (Guillermo), Nguewa, P.A. (Paul Alain)
Format: info:eu-repo/semantics/article
Language:English
Published: 2022
Subjects:
Leishmaniasis
Drug repurposing
Antimicrobial peptides (AMPs)
Peptide 19-2.5
Peptide 19-4LF
Drug resistance
Proliferation
Cytokines
Online Access:https://hdl.handle.net/10171/64799

Internet

https://hdl.handle.net/10171/64799

Similar Items